Physicochemical parameters of NO-containing gas flow affect wound healing therapy. An experimental study

被引:18
作者
Shekhter, Anatoly B. [1 ]
Pekshev, Alexander, V [2 ]
Vagapov, Andrey B. [2 ]
Telpukhov, Vladimir, I [1 ]
Panyushkin, Peter, V [1 ]
Rudenko, Tatyana G. [1 ]
Fayzullin, Alexey L. [1 ]
Sharapov, Nikolay A. [2 ]
Vanin, Anatoly F. [1 ,3 ]
机构
[1] IM Sechenov First Moscow State Med Univ, Moscow, Russia
[2] Bauman Moscow State Tech Univ, Moscow, Russia
[3] NN Semenov Inst Chem Phys, Kosygin Str 4, Moscow 119991, Russia
关键词
Wound healing; Gaseous nitric oxide; Nitric oxide therapy; Plasma-chemical NO generation; NO-containing gas flow; Plason device; GASEOUS NITRIC-OXIDE; AIR;
D O I
10.1016/j.ejps.2018.11.034
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Therapy of wounds and inflammatory diseases with NO-containing gas flows (NO-CGF) has proved to be effective in a longterm clinical practice. Plasma-chemical generation of nitric oxide occurs from atmospheric air in Plason device. For the purpose of modification and improvement of NO-therapy, effects of various physicochemical parameters of the NO-CGF on inflammatory and reparative processes in wounds were studied. Treatment of planar full-thickness skin wounds in laboratory rats was analyzed with morphological, immunohistochemical, morphometric and statistical methods. The study showed that the Plason device and the experimental device, which differs from Plason by the NO-CGF temperature, significantly reduce inflammatory and enhance regenerative processes in the wounds. The NO-CGF with an ambient temperature generated by the experimental device has noticeably facilitated the wound healing in direct ration to a nitric oxide content and flow velocity at the area of application. Temperature did not affect the course of wound healing process. The development of a new device for NO-therapy may be of use for both physicians and patients.
引用
收藏
页码:193 / 201
页数:9
相关论文
共 32 条
  • [1] Use of an Exogenous Nitric Oxide Generator for Treatment of Peritonitis
    Achkasov E.E.
    Esipov A.V.
    Pekshev A.V.
    Musailov V.A.
    [J]. Musailov, V.A. (musailove@mail.ru), 2018, Springer Science and Business Media, LLC (52) : 64 - 67
  • [2] [Anonymous], 1986, ETS123 PROTECTION VE, V18, pIII
  • [3] Nitric oxide enhancement strategies
    Bryan, Nathan S.
    [J]. FUTURE SCIENCE OA, 2015, 1 (01):
  • [4] Chirikova E. G., 2003, ROS MED ZH, V3, P14
  • [5] Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn.
    Clark, RH
    Kueser, TJ
    Walker, MW
    Southgate, WM
    Huckaby, JL
    Perez, JA
    Roy, BJ
    Keszler, M
    Kinsella, JP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (07) : 469 - 474
  • [6] Gaseous nitric oxide to treat antibiotic resistant bacterial and fungal lung infections in patients with cystic fibrosis: a phase I clinical study
    Deppisch, Caroline
    Herrmann, Gloria
    Graepler-Mainka, Ute
    Wirtz, Hubertus
    Heyder, Susanne
    Engel, Corinna
    Marschal, Matthias
    Miller, Christopher C.
    Riethmueller, Joachim
    [J]. INFECTION, 2016, 44 (04) : 513 - 520
  • [7] Multicenter, randomized controlled, observer-blinded study of a nitric oxide generating treatment in foot ulcers of patients with diabetes-ProNOx1 study
    Edmonds, Michael E.
    Bodansky, Harvey J.
    Boulton, Andrew J. M.
    Chadwick, Paul J.
    Dang, Cuong N.
    D'Costa, Ryan
    Johnston, Atholl
    Kennon, Brian
    Leese, Graham
    Rajbhandari, Satyan M.
    Serena, Thomas E.
    Young, Matthew J.
    Stewart, Joanne E.
    Tucker, Arthur T.
    Carter, Marissa J.
    [J]. WOUND REPAIR AND REGENERATION, 2018, 26 (02) : 228 - 237
  • [8] Fridman A, 2008, PLASMA CHEMISTRY, P1, DOI 10.1017/CBO9780511546075
  • [9] Applied plasma medicine
    Fridman, Gregory
    Friedman, Gary
    Gutsol, Alexander
    Shekhter, Anatoly B.
    Vasilets, Victor N.
    Fridman, Alexander
    [J]. PLASMA PROCESSES AND POLYMERS, 2008, 5 (06) : 503 - 533
  • [10] INOmax, 2016, INOMAX HAS WELL EST